跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Ulcerative Colitis therapeutic
首页
药物
Ulcerative Colitis therapeutic
Ulcerative Colitis therapeutic
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Antisense oligonucleotides (ODN) against Smad7 and uses in medical field thereof
US 7700757 B2
申请人: GIULIANI INTERNAITONAL LTD
优先权: 2003
US
25 件公开
PROTEINS FOR THE TREATMENT OF EPITHELIAL BARRIER FUNCTION DISORDERS
EP 3606542 B1
申请人: GENEVIVE INC
优先权: 2017
CN
EP
US
WO
7 件公开
US 11174293 B2
申请人: SECOND GENOME INC
优先权: 2018
US
3 件公开
US 11273198 B2
申请人: SECOND GENOME INC
优先权: 2018
US
2 件公开
US 20240043477 A1
申请人: SECOND GENOME INC
优先权: 2022
US
2 件公开
US 11666627 B2
申请人: SECOND GENOME INC
优先权: 2019
US
US 11505583 B2
申请人: SECOND GENOME INC
优先权: 2019
US
COMPOSITIONS AND USES THEREOF
EP 4103161 B1
申请人: BENEVOLENTAI CAMBRIDGE LTD
优先权: 2020
CN
EP
US
WO
6 件公开
Therapeutic agent for ulcerative colitis
US 2006083686 A1
申请人: AJINOMOTO KK
优先权: 2001
US
6 件公开
USE OF TIGHT JUNCTION ANTAGONISTS TO TREAT INFLAMMATORY BOWEL DISEASE
US 2009069247 A1
申请人: PATERSON BLAKE
优先权: 2007
US
6 件公开
ANTIBODIES TARGETING XCL1 AND METHODS OF USING THE SAME
EP 4719598 A2
申请人: LILLY CO ELI
优先权: 2023
CN
EP
US
WO
5 件公开
Therapeutic and diagnostic methods for ulcerative colitis and associated disorders
US 7122336 B2
申请人: UNIV NEW JERSEY MED
优先权: 2001
US
5 件公开
THERAPEUTIC BACTERIAL COMPOSITION
EP 4221728 A1
申请人: MICROBIOTICA LTD
优先权: 2020
CN
EP
US
WO
4 件公开
TOPICAL TREATMENT OF INFLAMMATORY BOWEL DISEASE USING ANTI-TNF-ALPHA ANTIBODIES AND FRAGMENTS THEREOF
EP 3409688 A1
申请人: TILLOTTS PHARMA AG
优先权: 2017
EP
US
4 件公开
Methods of suppressing or treating an inflammatory bowel disease by administering an antibody or portion thereof that binds to AILIM
US 7465444 B2
申请人: JAPAN TOBACCO INC
优先权: 2001
US
4 件公开
第 1 / 10 页
上一页
下一页
药物
反馈